Ioana Florea, MD

  • 2Articles
  • 22.2KReads
  • 2017–2023Active
  • 6Collaborators
  • 234Citations

About

Ioana Florea, MD, is affiliated with H. Lundbeck A/S in Valby, Denmark. Florea has published research focused on major depressive disorder (MDD), including comparative studies of antidepressant treatments and investigations into the effects of vortioxetine on cognitive functioning in working patients with MDD. Collaborators frequently include Michael Cronquist Christensen, Roger S. McIntyre, Brigitte Tonnoir, Henrik Loft, and Mads Møller Pedersen. Florea’s work has appeared in Psychiatrist.com since 2017.

Publications

JCP
Vortioxetine vs Desvenlafaxine in Patients With MDD
Original Research

Vortioxetine vs Desvenlafaxine in Patients With MDD

May 22, 2023

Compared with desvenlafaxine, vortioxetine was associated with higher rates of symptomatic and functional remission, better daily and social functioning, and greater treatment satisfaction in patients with major depression and...
, , , et al
JCP
Original Research

Vortioxetine and Cognition in Working Patients With MDD

January 25, 2017

Many studies have shown that people with MDD have reduced work productivity, and cognitive symptoms are common. This study looked at whether antidepressant treatment with vortioxetine would improve cognitive...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe